Idiopathic Parkinson's Disease
2 competing products in clinical development for Idiopathic Parkinson's Disease.
Pipeline by Phase
Phase 32
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Istradefylline 20 mg or 40 mg | Kyowa Kirin | Phase 3 | Completed | 40 |
| Istradefylline 40 mg + Istradefylline 20 mg + Placebo | Kyowa Kirin | Phase 3 | Completed | 40 |